Bluejay Diagnostics (BJDX) Asset Writedowns and Impairment (2022 - 2026)

Bluejay Diagnostics has reported Asset Writedowns and Impairment for 5 years, with the latest figure at $2880.0 in Q1 2026.

• Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $2880.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31577.0 (changed N/A YoY) and the FY2025 annual result came in at $26706.0, up 682.94% from the prior year.
• Asset Writedowns and Impairment climbed to $2880.0 in Q1 2026 per BJDX's latest filing, from -$10363.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $36574.0 in Q3 2025 and troughed at -$10363.0 in Q4 2025.
• A 5-year average of $6579.1 and a median of $354.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
• The widest YoY moves for Asset Writedowns and Impairment: up 10231.64% in 2025, down 516.85% in 2025.
• Over 5 years, Asset Writedowns and Impairment stood at $27192.0 in 2022, then tumbled by 101.77% to -$482.0 in 2023, then jumped by 615.77% to $2486.0 in 2024, then plunged by 516.85% to -$10363.0 in 2025, then jumped by 127.79% to $2880.0 in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $2880.0, -$10363.0, and $36574.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.